"L'Istituto di Ricerche Farmacologiche Mario Negri IRCCS è un'organizzazione scientifica che opera nel campo della ricerca biomedica."

During the past decade, Istituto Ricerche Farmacologiche Mario Negri IRCCS conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 2 clinical trials were completed. i.e. 40% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Istituto Ricerche Farmacologiche Mario Negri IRCCS" #1 collaborator was "Centre Hospitalier Universitaire Vaudois" with 1 trials as a collaborator, "Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico" with 1 trials as a collaborator, "Istituto Di Ricerche Farmacologiche Mario Negri" with 1 trials as a collaborator and "University College, London" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Istituto Ricerche Farmacologiche Mario Negri IRCCS" are "Chronic Kidney Disease" (2 trials), "Breast Cancer" (1 trials), "Communicable Diseases" (1 trials), "Development, Child" (1 trials) and "Evaluation" (1 trials). Many other conditions were trialed in "Istituto Ricerche Farmacologiche Mario Negri IRCCS" in a lesser frequency.

Most popular intervention types in "Istituto Ricerche Farmacologiche Mario Negri IRCCS" are "Drug" (3 trials), "Other" (3 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Blood Sampling" (1 trials), "Decision-aid" (1 trials), "Finerenone (BAY94-8862)" (1 trials) and "Finerenone (Kerendia, BAY94-8862)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Istituto Ricerche Farmacologiche Mario Negri IRCCS" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Istituto Ricerche Farmacologiche Mario Negri IRCCS". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Istituto Ricerche Farmacologiche Mario Negri IRCCS, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Istituto Ricerche Farmacologiche Mario Negri IRCCS, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

Istituto Ricerche Farmacologiche Mario Negri IRCCS has several departments that took part in Clinical trials: "Clinical Research Center for Rare Diseases" - 16 trials, "Clinical Research Center for Rare Diseases "Aldo e Cele Daccò"" - 4 trials, "Mario Negri Institute for Pharmacological Research" - 2 trials